Market Indices
Sector Heatmap
SMMT — Summit Therapeutics Inc. Common Stock
NasdaqSummit Therapeutics Inc. Common Stock
- O
- 17.61
- H
- 17.64
- L
- 16.80
- V
- 6.15M
SMMT — Latest News & Headlines
20 StoriesWhy Is SMMT Stock Tumbling Today? - Stocktwits
Why Is SMMT Stock Tumbling Today? Stocktwits
SMMT Stock Soars After-Hours: Did AstraZeneca Just End Summit’s Cash Scare? - Yahoo Finance
SMMT Stock Soars After-Hours: Did AstraZeneca Just End Summit’s Cash Scare? Yahoo Finance
Bernstein reiterates Summit Therapeutics stock rating on trial concerns - Investing.com
Bernstein reiterates Summit Therapeutics stock rating on trial concerns Investing.com
SMMT Stock Jumps As AstraZeneca Backs Ivonescimab Bet - Timothy Sykes
SMMT Stock Jumps As AstraZeneca Backs Ivonescimab Bet Timothy Sykes
Summit Therapeutics Rises as AstraZeneca Backs Ivonescimab With $2 Billion Investment - Quiver Quantitative
Summit Therapeutics Rises as AstraZeneca Backs Ivonescimab With $2 Billion Investment Quiver Quantitative
AstraZeneca Makes $2 Billion Strategic Equity Investment in Summit Therapeutics - Business Wire
AstraZeneca Makes $2 Billion Strategic Equity Investment in Summit Therapeutics Business Wire
Summit Therapeutics: Stronger Balance Sheet Helps, But It Does Not De-Risk Ivonescimab - Seeking Alpha
Summit Therapeutics: Stronger Balance Sheet Helps, But It Does Not De-Risk Ivonescimab Seeking Alpha
AstraZeneca Digs $2 Billion Out Of Its Coffers For Summit Deal, Taking On Bristol, Pfizer, Merck - Investor's Business Daily
AstraZeneca Digs $2 Billion Out Of Its Coffers For Summit Deal, Taking On Bristol, Pfizer, Merck Investor's Business Daily
Summit Shares Jump on $2B Strategic Investment From AstraZeneca - TradingView
Summit Shares Jump on $2B Strategic Investment From AstraZeneca TradingView
These stocks that are showing activity before the opening bell on Tuesday. - ChartMill
These stocks that are showing activity before the opening bell on Tuesday. ChartMill
SMMT Stock Gains After Summit Reports Strong Lung Cancer Survival Results — Investors Await Q2 Earnings - Stocktwits
SMMT Stock Gains After Summit Reports Strong Lung Cancer Survival Results — Investors Await Q2 Earnings Stocktwits
SMMT Inks Deal With AZN-Daiichi to Study Ivonescimab + Datroway Combos - Yahoo Finance
SMMT Inks Deal With AZN-Daiichi to Study Ivonescimab + Datroway Combos Yahoo Finance
Summit Therapeutics Rises as Investors Continue to Digest AstraZeneca Deal - Quiver Quantitative
Summit Therapeutics Rises as Investors Continue to Digest AstraZeneca Deal Quiver Quantitative
Biggest stock movers Tuesday: FICO, CCL, SMMT, NVTS, and more - Seeking Alpha
Biggest stock movers Tuesday: FICO, CCL, SMMT, NVTS, and more Seeking Alpha
SMMT Stock Gets Another Catalyst: Summit, AstraZeneca, Daiichi Sankyo Expand Cancer Drug Push - Stocktwits
SMMT Stock Gets Another Catalyst: Summit, AstraZeneca, Daiichi Sankyo Expand Cancer Drug Push Stocktwits
AstraZeneca (AZN) Puts $2 Billion Into Summit Therapeutics (SMMT) for a Cancer Tie-Up - Yahoo Finance
AstraZeneca (AZN) Puts $2 Billion Into Summit Therapeutics (SMMT) for a Cancer Tie-Up Yahoo Finance
Summit’s Global Lung Cancer Trials Gain Credibility After Akeso’s Phase 3 Data, Says Guggenheim - Stocktwits
Summit’s Global Lung Cancer Trials Gain Credibility After Akeso’s Phase 3 Data, Says Guggenheim Stocktwits
Summit Therapeutics (SMMT), What Is Behind The Fresh Attention? - Yahoo Finance
Summit Therapeutics (SMMT), What Is Behind The Fresh Attention? Yahoo Finance
Summit Therapeutics (SMMT) Is Up 7.3% After $2 Billion AstraZeneca Partnership and Trial Collaboration - Yahoo Finance
Summit Therapeutics (SMMT) Is Up 7.3% After $2 Billion AstraZeneca Partnership and Trial Collaboration Yahoo Finance
SMMT Oct 2026 18.500 call (SMMT261002C00018500) Stock Price, News, Quote & History - Yahoo! Finance Canada
SMMT Oct 2026 18.500 call (SMMT261002C00018500) Stock Price, News, Quote & History Yahoo! Finance Canada